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Abstract
Cocaine dependence (CD) is a multifactorial disorder, variable in its manifestations, and heritable.
We examined the concurrent validity of homogeneous subgroups of CD as phenotypes for genetic
analysis. We applied data reduction methods and an empirical cluster-analytic approach to measures
of cocaine use, cocaine-related effects, and cocaine treatment history in 1393 subjects, from 660
small nuclear families. Four of the six clusters that were derived yielded heritability estimates in
excess of 0.3. Linkage analysis showed genomewide significant results for two of the clusters. Here
we examine the concurrent validity of the six clusters using a variety of demographic and substance-
related measures. In addition to being differentiated by a variety of cocaine-related measures, the
clusters differed significantly on measures that were independent of those used to generate the
clusters, i.e., demographic features and prevalence rates of co-morbid substance use and psychiatric
disorders. These findings support the validity of the methods used to derive homogeneous subgroups
of CD subjects and the resulting CD subtypes. Independent replication of these findings would
provide further validation of this approach.
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1. INTRODUCTION
Cocaine use is widespread in the U.S., producing a variety of adverse medical and
neuropsychiatric effects (Wolff and O’Donnell, 2004; Karch, 2005; Nnadi et al., 2005;
Substance Abuse and Mental Health Services Administration, 2004). Cocaine dependence
(CD), as a broad diagnostic entity, is a complex, heterogeneous, multifactorial disorder that
includes cognitive, behavioral, and physiologic features. One way to reduce the heterogeneity
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of CD is the use of a typologic (or subtyping) approach (Babor and Dolinsky, 1988; Epstein,
2001). The validity of such an approach can be evaluated in terms of the utility of the subtypes
for understanding etiology, presentation, natural history, or response to treatment of individuals
with CD.
Vulnerability to the development of CD varies among individuals. Studies in animals and
humans have examined the relative contributions of environmental and genetic factors in the
etiology of substance dependence (Uhl et al., 1995). Elucidating the genetic basis of CD would
represent major progress in understanding the etiology of the disorder and could contribute
substantially to the effort to develop efficacious medications to treat the disorder. This effort
has, to date, been largely unsuccessful (Kosten et al., 2005). The failure to identify efficacious
medications to treat cocaine dependence may reflect an inadequate understanding of the
heterogeneity of the disorder or an incomplete understanding of the pathophysiology of the
disorder, with inadequate specification of potential medication-responsive dimensions.
Twin studies have shown that cocaine and other stimulant dependence is genetically influenced
(Tsuang et al., 1996; Kendler and Prescott, 1998; Kendler et al., 2003). Although these studies
considered CD as a single diagnostic entity, there appear to be multiple subtypes of CD (Weiss
and Mirin, 1986). If the broader set of CD subjects could be decomposed into valid subgroups,
members of which were more similar phenotypically to each other than to members of other
groups, these more homogenous subgroups could provide a basis for more powerful genetic
analysis.
Univariate approaches for subtyping CD have focused on co-occurring psychopathology
(Rounsaville et al., 1991), family history of substance abuse (Roehrich and Gold, 1988) and
personality dimensions (Craig and Olson, 1992; Ball et al., 1998). Multivariate approaches to
subtyping CD and other drug dependence (Ball et al., 1995; Feingold et al., 1996; Cohen,
1999; Basu et al., 2004) have used an empirical (k-means) clustering technique that was first
applied to differentiate alcoholics into Type A (i.e., low-risk/severity) and Type B (i.e., high-
risk/severity) subtypes (Babor et al., 1992). The present study describes a multivariate cluster
analytic approach that has been refined from those used previously to yield cluster assignments
for use in a genome-wide linkage analysis.
In our genome-wide linkage study of CD (Gelernter et al., 2005), we examined CD as a unified
entity and used cluster analysis to identify subgroups that may vary in terms of heritability and
of the genes underlying their vulnerability. Based on a six-cluster solution, we found interesting
linkage results with two of these clusters. In this manuscript, we provide evidence for the
concurrent validity of these clusters by comparing the subtypes on a variety of cocaine-related
features, as well as the prevalence of co-morbid substance use and psychiatric disorders.
2. METHODS
2.1. Subjects
We recruited 1393 subjects, from 660 small nuclear families. Of these families, 482 had at
least 2 siblings with CD, 207 had at least 2 siblings with opioid dependence, and 156 had at
least 2 siblings with both CD and opioid dependence. The average age of subjects was 39.2
years (range 17-79) and 51.8% were women. The majority of subjects (57.1%) were never
married, 27% were divorced, separated, or widowed, and 15.9% were married. The ethnic/
racial distribution of the sample was 49.6% African-American (AA), 33.0% European-
American (EA), 12.6% Hispanic, and 4.8% Native American, Pacific Islander or members of
other minority groups (according to subject self-report). With respect to level of education,
7.3% had only completed grade school; 39.5% had some high school, but no diploma; 30.7%
had completed high school; and 22.6% had education beyond high school.
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The most common lifetime DSM-IV (American Psychiatric Association, 1994) substance use
and psychiatric disorders are shown in Table 1, both in the aggregate and separately by sex.
Nearly 90% of individuals were cocaine dependent, as might be expected given that
ascertainment was based primarily on that diagnosis. Nicotine dependence was the next most
common diagnosis, with approximately two-thirds of individuals receiving that diagnosis,
followed by alcohol dependence and opioid dependence, each with a prevalence of about 45%,
and cannabis dependence, occurring in just over one-quarter of the sample. Major depressive
episode (MDE) was the most common psychiatric disorder, with a prevalence of nearly 15%,
followed by antisocial personality disorder (ASPD), which was diagnosed in about 12% of
individuals. The frequency of posttraumatic stress disorder (PTSD) and compulsive gambling
each approached 10%.
There was no sex difference in the prevalence of CD or nicotine dependence, or the less
commonly diagnosed sedative dependence and stimulant (other than cocaine) dependence.
However, men were significantly more likely to receive diagnoses of alcohol dependence,
opioid dependence, and other substance (i.e., PCP, hallucinogens, inhalants, solvents, or
combinations such as “speedballs”) dependence, as well as ASPD and compulsive gambling.
In contrast, women were more likely to receive a diagnosis of MDE, PTSD, panic disorder, or
agoraphobia.
2.2. Procedure
Small nuclear families were recruited for participation in genomewide linkage studies of CD
and opioid dependence. All subjects gave written, informed consent to participate, using
procedures approved by the institutional review board at each participating site. Inclusion
required the participation of a sibling pair, both members of which were affected with a lifetime
diagnosis of either CD, opioid dependence, or both. Additional family members, including
parents and other siblings (irrespective of their having a lifetime substance dependence
diagnosis), were also invited to participate. Recruitment was conducted at substance abuse
treatment programs and through clinical referrals and advertisements in local media in
Connecticut (through sites at Yale University and the University of Connecticut); Boston, MA
(McLean Hospital) and Charleston, SC (Medical University of South Carolina). Data were
submitted electronically to a database at Boston University, where analysis was conducted.
2.3. Assessments
Phenotypic information was obtained through administration of the SSADDA (Pierucci-Lagha
et al., 2005), which includes a separate section for the diagnosis of cocaine dependence.
Questions from the Addiction Severity Index (McLellan et al., 1992) were added to the
SSADDA, to allow the estimation of lifetime measures of substance (including cocaine) use.
The SSADDA was formatted for computer-assisted administration, incorporating automated
skip patterns and logical data-entry checks. The reliability of the SSADDA has been shown to
be good-to-excellent for all of the major substance dependence diagnoses (Pierucci-Lagha et
al., 2005). Specifically, the test-retest and inter-rater reliabilities for CD dependence diagnosed
using criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV; American Psychiatric Association, 1994) were 0.92 and 0.83, respectively. Items
(n = 68) from the cocaine use disorder section of the SSADDA were used to generate the
clusters. These included age of onset and frequency and intensity of cocaine use, route of
cocaine administration, occurrence of psychosocial and medical consequences of cocaine use,
quit attempts, and cocaine abuse treatment sought and received.
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2.4. Data Analysis
All items from the cocaine use disorders section of the Semi-Structured Assessment for Drug
Dependence and Alcoholism (SSADDA; Pierucci-Lagha et al., 2005) were used initially in the
development of subtypes. Multiple correspondence analysis (MCA) (Greenacre, 1984; Lebart
et al., 1984), a non-parametric data reduction method, was used to identify the underlying
dimensions in the data from the CD section of the SSADDA (as briefly described previously
in Gelernter et al., 2005). Binary symptoms included cocaine use characteristics, cocaine-
related effects, and cocaine treatment history. Each study participant with phenotypic data was
assigned a score on each of the retained dimensions (data not shown). An iterative k-means
partitioning, using nearest centroid sorting (Hirano et al. 2003), was then conducted using
several different starting points and a larger than expected number of clusters (k=50). Starting
with a number of clusters that is far higher than a number we would accept as a final solution
allows the identification of stable small groups. The next stage involved cross-classification
of the results of the k-means clustering and retention of the groups that consistently clustered
together. These groups and the remaining observations were then used in an agglomerative
hierarchical clustering, with Ward’s method (Ward 1963) serving to identify the final cluster
structure. Ward’s method avoids the idiosyncrasies that can occur with different starting seeds
for k-means clustering by identifying intact groups for the hierarchical clustering that are joined
prior to the agglomerative process (Hirano et al. 2003). It thereby retains the strengths of both
types of clustering while mitigating the weaknesses. The selection of the final subgroup
structure was based on a comparison of the within-to-between-group variation on items used
to form the groups and group profiles on other variables. We considered solutions with larger
numbers of clusters, though with more than six clusters, single individuals or small groups of
outliers emerged, making it impossible to interpret the solution.
Binary logistic regression was used to estimate the probability of cluster membership for each
study participant in each of the clusters. Variables selected for clustering were used in the
estimation of the probability of cluster membership. Each study participant was assigned a
score on each of the retained dimensions using a procedure similar to the assignment of factor
scores. The natural logarithm of the probability of membership in each group was the dependent
measure in the quantitative trait analyses. Chi-square analysis was used to compare clusters on
categorical measures and analysis of variance (ANOVA) was used to compare clusters on
continuous measures.
SPAD software (DECISIA: Paris, France; http://eng.spad.eu) was used for both the MCA and
the clustering algorithms [see Ambrogi et al. (2005) for an alternate, compatible approach].
SAS software (SAS Institute, 2001) was used for subsequent analyses, including cluster
profiling. Heritability of the log of probability of group membership was computed using
Sequential Oligogenic Linkage Analysis Routines (SOLAR; Almasy and Blangero, 1998),
with sex as a covariate. We used linkage analysis methods to identify regions of chromosomes
that harbor genes influencing risk for CD; those are beyond the scope of the present report and
are described in detail in Gelernter et al. (2005).
3. RESULTS
3.1. Overview of Cluster Analysis Results
As shown in Table 2, cluster analysis yielded a 6-cluster solution, with the following
distribution of individuals (% of the total) across the 6 clusters: Cluster 1 [“Heavy, Cocaine
Use Predominant,” N = 336 (24.1%)], Cluster 2 [“Heavy, Mixed Drug Injector,” N = 303
(21.8%)], Cluster 3 [“Heavy Cocaine Use, Later Onset,” N = 350 (25.1%)], Cluster 4
[“Moderate Cocaine and Opioid Use,” N = 258 (18.5%)], Cluster 5 [“Low Cocaine and Opioid
Abuse,” N = 104 (7.5%)], and Cluster 6 [“Opioid Abuse,” N = 42 (3%)]. Comparison of the
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clusters on demographic features showed significant differences among clusters on age, sex,
race, and marital status. Clusters 1 and 3 contain predominantly AA women who were never
married. Cluster 2 has the oldest subjects, contains the fewest women, and, together with
Clusters 5 and 6, the fewest AAs. Clusters 2 and 6 also contain the largest percentage of
individuals who were divorced, separated, or widowed. Although Clusters 4, 5, and 6 are all
roughly evenly divided by sex, with the majority of individuals in each having never married,
these clusters differ substantially from one another on race, with Cluster 5 containing the largest
proportion of Hispanics.
3.2. Features of Cocaine Use Behavior by Cluster
The clusters were clearly differentiated on cocaine use characteristics, cocaine-related effects,
and on cocaine treatment history (Table 3).
3.2.1. Heavy Cocaine Use Clusters—Consistent with the prevalence of CD in the clusters,
Clusters 1, 2, and 3 each included a high percentage of individuals who reported having used
cocaine daily or almost daily (96.2%, 96.4% and 92.0%, respectively). However, members of
Clusters 1 and 2 reported earlier ages of initial cocaine use and of heaviest use than members
of Cluster 3. Members of Cluster 1 were more likely than those of Clusters 2 or 3 to endorse
having gotten higher and stayed higher longer than others when they first started to use cocaine.
With respect to other measures of cocaine-related effects, including adverse ones, Clusters 1
and 2 were comparable to one another and generally higher than all other clusters, including
Cluster 3. Subjects in Clusters 1 and 2 were more likely than those in Cluster 3 to have received
formal treatment for cocaine abuse, but comparable proportions of the three clusters reported
ever having attended a self-help group meeting due to cocaine abuse.
Cluster 2 members were predominantly intravenous cocaine users who progressed to their
periods of heaviest cocaine use sooner after initiating cocaine use than did the members of
Clusters 1 or 3 (6.8 vs. 8.3 years for both Clusters 1 and 3). The high rate of intravenous drug
use is consistent with the high rate of opioid dependence in this cluster.
As shown in Table 3, members of Cluster 3 were more likely than those in Clusters 4, 5, or 6
to endorse a variety of cocaine use characteristics and cocaine-related effects. However, Cluster
3 individuals reported a later age of initial cocaine use than did Cluster 4 members, and their
heaviest use occurred later than it did for members of Clusters 4, 5, or 6.
3.2.2. Low-to-Moderate Cocaine Use Clusters—Although more than 90% of Cluster 4
members endorsed having used cocaine daily or almost daily, the prevalence of cocaine
dependence was lower in this cluster than for the heavy cocaine use clusters. However, Cluster
4 had a higher prevalence of opioid dependence and a higher rate of intravenous cocaine use
than did Clusters 1 or 3. More than one-third of Cluster 5 members met criteria for CD, though
fewer than 3% endorsed daily or almost daily use of cocaine. However, more than 40% of this
cluster met criteria for opioid dependence and nearly 20% endorsed intravenous cocaine use.
Both Clusters 4 and 5 contained substantial proportions of individuals who endorsed cocaine-
related effects and cocaine treatment histories.
3.2.3. Occasional or No Cocaine Use Cluster—Members of Cluster 6 reported the latest
onset of both cocaine use and heavy cocaine use among the clusters. Cluster 6 also consistently
had the lowest proportion of members who endorsed cocaine-related effects and cocaine
treatment. However, this cluster had the second-highest prevalence of opioid dependence.
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3.3. Substance Dependence and Psychiatric Disorders by Cluster
As can be seen in Table 4, more than 99% of individuals in Clusters 1-3 met lifetime DSM-IV
diagnostic criteria for CD, a significantly higher percentage than that in Clusters 4, 5, or 6
(78%, 38%, and 7%, respectively, all significantly different from one another). Based on these
findings and other characteristics described below, we identified these groups as Heavy
Cocaine Use (Clusters 1-3), Low-to-Moderate Cocaine Use (Clusters 4 and 5), and Occasional
or No Cocaine Use (Cluster 6) clusters.
Significant differences exist among the clusters on the lifetime prevalence of all other substance
dependence diagnoses (Table 4). The Heavy Cocaine Use clusters showed a higher prevalence
of nearly all substance dependence diagnoses than the other three clusters (which did not differ
consistently from one another). Of the Heavy Cocaine Use clusters, Cluster 2 showed the
highest prevalence of all categories of substance dependence, particularly opioid dependence;
Clusters 4, 5, and 6 also showed a high prevalence of opioid dependence, despite having a
lower prevalence of the other substance dependence diagnoses. The prevalence of cannabis
dependence was highest in Clusters 1 and 2, with Clusters 3 and 4 being intermediate, and
Clusters 5 and 6 having the lowest prevalence of this disorder.
Subjects in Clusters 1 and 2 also had the highest prevalence of major depressive episode
(MDE), antisocial personality disorder (ASPD), and posttraumatic stress disorder (PTSD), with
no consistent pattern of differences among the other clusters on these disorders. Differences
in the prevalence of compulsive gambling, panic disorder, and agoraphobia showed a similar
pattern, but were less pronounced, possibly due to the lower overall prevalence of these
disorders.
Although not a co-morbid disorder, cocaine-induced paranoia (CIP) is a psychopathologic
feature that occurs commonly among individuals with CD (Satel et al., 1991a; Brady et al.,
1991; Rosse et al., 1995; Bartlett et al., 1997; Cubells et al., 2005). There is evidence that CIP
is genetically influenced (Gelernter et al., 1994; Cubells et al., 2000). The prevalence of CIP
varied significantly across clusters in a pattern similar to the co-morbid substance use and
psychiatric disorders (Cluster 1: 87.5%, Cluster 2: 78.2%, Cluster 3: 52.9%, Cluster 4: 38.4%,
Cluster 5: 35.6%, Cluster 6: 4.8%) [□2(5) = 295.8, p < 0.001].
3.4. Heritability of the Clusters
All of the clusters showed significant heritability, with the estimate for each of the first four
clusters exceeding 30% (Table 5). Although the size of the clusters was not fully explained by
their size, the two smallest clusters (Clusters 5 and 6) showed the lowest heritability estimates.
3.5. Linkage Analysis of the Clusters
As reported previously, we (Gelernter et al., 2005) conducted linkage analysis on a sub-sample
of 986 individuals from the present study sample using CD diagnosis, CIP, and cluster
membership as phenotypes. Interestingly, of the phenotypes examined (which included DSM-
IV CD, CIP, and cluster membership), the strongest linkage results were observed for cluster
membership. These findings included a lod score of 4.66 for membership in Cluster 1 on
chromosome 12 (in EAs only) and a lod score of 3.35 for membership in Cluster 4 on
chromosome 18 (in AAs only). In addition, there was suggestive evidence of linkage for Cluster
1 on chromosome 3 (in EAs only), for Clusters 1 or 3 on chromosome 6 (in the total sample),
and for Cluster 3 on chromosome 2 (in AAs only).
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4. DISCUSSION
DSM-IV CD may not represent the optimal CD-related phenotype for genetic mapping; other
phenotypes might identify more genetically homogeneous sets of subjects. Based on
demographic characteristics and cocaine use histories, we used a cluster analytic approach to
identify phenomenologically distinct CD clusters. Subjects in Clusters 1, 2, and 3 were
characterized by a history of heavy cocaine use, a high degree of CD severity (measured by
the vast majority of individuals in these clusters having endorsed enough cocaine dependence
symptoms to receive a diagnosis of CD). A preponderance of individuals in these clusters also
reported having participated in both self-help recovery programs and formal treatment for
cocaine abuse. In addition, although these measures were not included as variables in the cluster
analysis, members of the heavy cocaine use clusters (particularly those in Clusters 1 and 2)
were substantially more likely to meet diagnostic criteria for a variety of other substance
dependence and co-morbid psychiatric disorders.
Cluster analysis, which is used to classify a set of observations into two or more mutually
exclusive groups based on a set of interval measures, results in a solution in which members
of the groups share properties in common (Stockburger, 1998). Cluster analysis allows many
choices about the nature of the algorithm for combining groups and, although it will always
produce a grouping, the structure of the resultant solution will vary with the method employed,
the cases included in the analysis, and the quality of the data used in the analysis. To address
these concerns, we applied a multi-staged, iterative approach to identify cluster membership,
which effectively repeated the clustering to achieve stable groups. The advantages of the
modified strategy are that the clustering is repeated with several starting points and two
different methods are used to obtain stable clusters, which should increase the generalizability
of the cluster results. In addition, careful quality assurance procedures were employed in data
collection using the SSADDA (Pierucci-Lagha et al., 2005), which is likely to have reduced
variance attributable to poor reliability of the assessment. These factors may help to explain
why the six-cluster solution obtained here differs from the two-cluster solution obtained
previously in samples of cocaine- and other drug-dependent individuals analyzed using a
simple k-means clustering procedure (Ball et al., 1995; Feingold et al., 1996; Ball et al.,
1998; Basu et al., 2004). In addition to the different analytic approach, the current study sample
differs from the clinical samples recruited in prior studies, in that the family-based recruitment
approach led to the inclusion of a substantial number of individuals without drug dependence
diagnoses.
The validity of the cluster solution was supported by its capacity to discriminate between
variables that were not used to create the grouping (Stockburger, 1998). That is, the clusters
differed significantly on demographic features, but also particularly on prevalence rates of co-
morbid substance use and psychiatric disorders. The differences among the clusters were
further confirmed by estimates of the heritability of the trait embodied in cluster membership,
which was greatest for the heavy cocaine use clusters. Because the sample was ascertained
using an affected sib pair strategy, the heritability estimates may be inflated; consequently,
they were treated as directional, and were used to select traits to examine with a genomewide
linkage analysis (Gelernter et al., 2005). Linkage analysis yielding genomewide significant
findings in a sub-sample of individuals from the sample described herein using cluster
membership as phenotypes provides further validation of the subtyping procedure.
These findings lend support to the use of a data reduction and cluster-analytic strategy to
provide more homogeneous subgroups of CD subjects for linkage analysis. Because the choice
and implementation of the clustering algorithm, as well as data quality and the stability of the
underlying groups can influence the likelihood of replicating the results of cluster analyses,
we applied a multi-staged approach to identify cluster membership. The advantages of this
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strategy are that the clustering is repeated with several starting points and two different methods
are used to obtain stable clusters, increasing the generalizability of the cluster results.
This novel application of clinical subtyping to a molecular genetic investigation of drug
dependence is consistent with prior efforts to explain the phenotypic variability among
alcoholics (Cloninger et al., 1981; Babor et al., 1992) and drug abusers (Ball et al., 1995;
Feingold et al., 1996; Ball et al., 1998; Basu et al., 2004). The approach satisfied a stringent
criterion for validity of the cluster structure by demonstrating its utility as a phenotype for
linkage analysis. Further analysis of the subtypes provided evidence of their concurrent
validity. By reducing genetic heterogeneity, this subtyping approach represents a powerful and
useful refinement for the diagnosis of CD. Replication of the findings reported here in a second
sample of individuals with CD would add further to evidence of the validity and utility of this
approach.
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Table 5
Heritability Estimates for the Clusters
Cluster Number and Description Heritability (h2) P-Value
1. Heavy, Cocaine Predominant 0.387 0.0000060
2. Heavy, Mixed Drug Injectors 0.438 0.0000006
3. Heavy, Later Onset 0.501 0.0000000
4. Moderate Cocaine and Opioid Abuse 0.320 0.0002900
5. Low Cocaine and Opioid Abuse 0.238 0.0025000
6. Opioid Abuse 0.145 0.0398000
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